EPIX
ESSA Pharma Inc.
$0.21
-$0.01(-4.42%)
54
Overall
--
Value
54
Tech
--
Quality
Market Cap
$9.14M
Volume
1.93M
52W Range
$0.19 - $6.77
Target Price
$1.70
Order:
Income Statement
| Metric | Trend | Chart | 2018 Sep | 2019 Sep | 2020 Sep | 2021 Sep | 2022 Sep | 2023 Sep | 2024 Sep |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $10.8M | $12.8M | $24.1M | $37.2M | $37.0M | $32.1M | $34.4M | ||
| Research & Development | $4.9M | $6.7M | $12.1M | $24.3M | $24.4M | $21.3M | $21.2M | ||
| Research Expense | $4.9M | $6.7M | $12.1M | $24.3M | $24.4M | $21.3M | $21.2M | ||
| Selling, General & Administrative | $5.9M | $5.5M | $11.4M | $12.9M | $12.5M | $10.8M | $13.2M | ||
| Selling & Marketing Expenses | -- | $602.7K | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $5.9M | $5.5M | $11.4M | $12.9M | $12.5M | $10.8M | $13.2M | ||
| Salaries & Wages | $-1.4M | $1.1M | -- | -- | -- | -- | -- | ||
| Amortization | -- | -- | $110.3K | $109.5K | $121.8K | $118.5K | $90.7K | ||
| Other Operating Expenses | -- | $-602.7K | $-618.1K | $-22.2K | $-13.7K | -- | $69.2K | ||
| OPERATING INCOME | |||||||||
| Operating income | $-10.8M | $-11.5M | $-22.9M | $-37.1M | $-36.9M | $-32.1M | $-34.4M | ||
| EBITDA | $-12.2M | $-10.8M | $-23.0M | $-36.7M | $-34.9M | $-26.5M | $-28.5M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | $-563.3K | $-401.9K | $618.1K | $22.2K | $13.7K | $6.9K | -- | ||
| Interest Income Operating | -- | $26.3K | $559.7K | $235.0K | -- | -- | -- | ||
| Intinc | $42.7K | $26.3K | -- | $235.0K | $1.7M | $5.6M | $5.9M | ||
| Net Non-Operating Interest Income/Expense | $42.7K | $26.3K | -- | $235.0K | $-1.7M | $5.6M | $5.9M | ||
| Gain on Sale of Securities | -- | $1.2K | $-110.9K | $107.0K | $20.4K | -- | -- | ||
| Other Income/Expense | $-67.4K | $-1.2K | $110.9K | $-107.0K | $22.0K | $6.5K | -- | ||
| Other Special Charges | $2.0M | $2.8M | -- | -- | -- | -- | -- | ||
| SPECIAL ITEMS | |||||||||
| Special Income Charges | $-912.0K | -- | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-12.2M | $-10.8M | $-23.1M | $-36.8M | $-35.2M | $-26.6M | $-28.6M | ||
| Pre-Tax Income | $-11.6M | $-12.7M | $-23.7M | $-36.8M | $-35.2M | $-26.6M | $-28.5M | ||
| INCOME TAX | |||||||||
| Tax Provision | $27.0K | $37.9K | $-288.6K | $-34.3K | $-111.8K | $1.6K | $-10.0K | ||
| NET INCOME | |||||||||
| Net Income | $-11.6M | $-12.8M | $-23.4M | $-36.8M | $-35.1M | $-26.6M | $-28.5M | ||
| Net Income (Continuing Operations) | $-11.6M | $-12.8M | $-23.4M | $-36.8M | $-35.1M | $-26.6M | $-28.5M | ||
| Net Income (Discontinued Operations) | $-11.6M | $-12.8M | $-23.4M | $-36.8M | $-35.1M | $-26.6M | $-28.5M | ||
| Net Income (Common Stockholders) | $-11.6M | $-11.6M | $-23.4M | $-36.8M | $-35.1M | $-26.6M | $-28.5M | ||
| Normalized Income | -- | -- | -- | $-36.9M | -- | -- | $-28.6M | ||
| TOTALS | |||||||||
| Total Expenses | $10.8M | $12.8M | $24.1M | $37.2M | $37.0M | $32.1M | $34.4M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $4.6M | $8.4M | $22.4M | $38.5M | $44.0M | $44.1M | $44.3M | ||
| Average Shares Outstanding (Diluted) | $4.6M | $8.4M | $22.4M | $38.5M | $44.0M | $44.1M | $44.3M | ||
| Shares Outstanding | $5.8M | $20.8M | $33.6M | $44.0M | $44.1M | $44.1M | $44.4M | ||
| Basic EPS | $-2.55 | $-1.24 | $-1.04 | $-0.96 | $-0.80 | $-0.60 | $-0.64 | ||
| Basic EPS (Continuing Operations) | -- | $-1.24 | $-1.04 | $-0.96 | $-0.80 | $-0.60 | $-0.64 | ||
| Diluted EPS | -- | $-1.24 | $-1.04 | $-0.96 | $-0.80 | $-0.60 | $-0.64 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-0.80 | $-0.60 | $-0.64 | ||
| OTHER METRICS | |||||||||
| Acquisition Expense | -- | $64.8K | -- | -- | -- | -- | -- | ||
| Allowances For Construction | -- | $-2.3M | -- | -- | -- | -- | -- | ||
| Commission Expenses | -- | $602.7K | -- | -- | -- | -- | -- | ||
| Development Expense | $912.0K | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | $-83.7K | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | $912.0K | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $5.9M | $5.5M | $11.4M | $12.9M | $12.5M | $10.8M | $13.2M | ||
| Rent And Landing Fees | $5.9M | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EPIX | $0.21 | -4.4% | 1.93M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |